Last updated: August 17, 2026
Amgen is delighted to announce the launch of the
PCSK9 Competitive Grant Program
, which will provide an opportunity for investigators from around the world to compete for individual grants of up to 200,000 USD for novel research proposals that seek to advance the understanding of PCSK9 and atherosclerosis.
The program is global in reach and is open to proposals from established and junior investigators*.
The deadline for applications is Friday, May 11, 2018 (11:59 pm US Pacific Time).
*Junior investigators should be within 5 years of completion of training
Scientific Case Review
Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?
Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.
- Review of the information you provide
- Relevant research and clinical program information
- A clear response focused on your situation
No obligation. Your question will be reviewed confidentially.
Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.
